The CD8+HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls

European Journal of Immunology

Volumn 42, Issue 10, 2012, Pages 2608-2620

  Imamichi, Hiromi ^a   Lempicki, Richard A ^b   Adelsberger, Joseph W ^b   Hasley, Rebecca B ^a   Rosenberg, Alice ^b   Roby, Gregg ^a   Rehm, Catherine A ^a   Nelson, Amy ^a   Krishnan, Sonya ^b   Pavlick, Mark ^a   Woods, Christian J ^c   Baseler, Michael W ^b   Lane, H Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Activated CD8+ T cells; Cell cycle; HIV; HLA DR; Immune activation

Indexed keywords

CYCLIN A2; CYCLIN DEPENDENT KINASE 1; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIVISION; CELL EXPANSION; CELL FRACTIONATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOSTIMULATION; IN VIVO STUDY; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CLONAL ANERGY; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 84867196871     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142046     Document Type: Article

References (37)

1. Grossman, Z., Meier-Schellersheim, M., Paul, W. E. and Picker, L. J., Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 2006. 12: 289-295.
2. Lane, H. C., Masur, H., Gelmann, E. P., Longo, D. L., Steis, R. G., Chused, T., Whalen, G. et al., Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am. J. Med. 1985. 78: 417-422.
3. Phillips, A. N., Sabin, C. A., Elford, J., Bofill, M., Lee, C. A. and Janossy, G., CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 1993. 7: 975-980.
4. Phillips, A. N., Neaton, J. and Lundgren, J. D., The role of HIV in serious diseases other than AIDS. AIDS 2008. 22: 2409-2418.
5. Monforte, A., Abrams, D., Pradier, C., Weber, R., Reiss, P., Bonnet, F., Kirk, O. et al., HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008. 22: 2143-2153.
6. Weber, R., Sabin, C. A., Friis-Moller, N., Reiss, P., El-Sadr, W. M., Kirk, O., Dabis, F. et al., Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 2006. 166: 1632-1641.
7. Kuller, L. H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B. et al., Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008. 5: e203.
8. Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C. et al., Plasma levels of soluble CD14 independently predict mortality in HIV infection. J. Infect. Dis. 2011. 203: 780-790.
9. Giorgi, J. V. and Detels, R., T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 1989. 52: 10-18.
10. Kestens, L., Vanham, G., Gigase, P., Young, G., Hannet, I., Vanlangendonck, F., Hulstaert, F. and Bach, B. A., Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. AIDS 1992. 6: 793-797.
11. Giorgi, J. V., Liu, Z., Hultin, L. E., Cumberland, W. G., Hennessey, K. and Detels, R., Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T-cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune. Defic. Syndr. 1993. 6: 904-912.
12. Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R. et al., Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 1999. 179: 859-870.
13. Hazenberg, M. D., Otto, S. A., van Benthem, B. H., Roos, M. T., Coutinho, R. A., Lange, J. M., Hamann, D., Prins, M. and Miedema, F., Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003. 17: 1881-1888.
14. Hara, T., Hisano, S., Mizuno, Y., Hatae, K., Kurokawa, M., Ueda, K., Sakaguchi, T. et al., Systemic lupus erythematosus of childhood onset: correlation between T cells expressing early and late activation antigens and disease activity. Eur. J. Pediatr. 1989. 148: 626-629.
15. Ishihara, K., Yoshimura, M., Nakao, H., Kanakura, Y., Kanayama, Y. and Matsuzawa, Y., T-cell abnormalities in mixed connective tissue disease complicated with Klinefelter's syndrome. Intern. Med. 1994. 33: 714-717.
16. Scolozzi, R., Boccafogli, A., Tola, M. R., Vicentini, L., Camerani, A., Degani, D., Granieri, E. et al., T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 1992. 108: 93-98.
17. Yoshiike, T., Aikawa, Y., Wongwaisayawan, H. and Ogawa, H., HLA-DR antigen expression on peripheral T-cell subsets in pityriasis rosea and herpes zoster. Dermatologica 1991. 182: 160-163.
18. Tomita, T., Kashiwagi, N., Shimaoka, Y., Ikawa, T., Tanabe, M., Nakagawa, S., Kawamura, S. et al., Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J. Rheumatol. 1994. 21: 1608-1614.
19. Ikeda, M., Watanabe, Y., Kitahara, S. and Inouye, T., Distinctive increases in HLA-DR+ and CD8+57+ lymphocyte subsets in Wegener's granulomatosis. Int. Arch. Allergy Immunol. 1993. 102: 205-208.
20. Rea, I. M., McNerlan, S. E. and Alexander, H. D., CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp. Gerontol. 1999. 34: 79-93.
21. Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P. and Miedema, F., Programmed death of T cells in HIV-1 infection. Science 1992. 257: 217-219.
22. Gougeon, M. L., Garcia, S., Heeney, J., Tschopp, R., Lecoeur, H., Guetard, D., Rame, V. et al., Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses 1993. 9: 553-563.
23. Lewis, D. E., Tang, D. S., Adu-Oppong, A., Schober, W. and Rodgers, J. R., Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J. Immunol. 1994. 153: 412-420.
24. Mahalingam, M., Pozniak, A., McManus, T. J., Vergani, D. and Peakman, M., Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Clin. Exp. Immunol. 1995. 102: 481-486.
25. Catalfamo, M., Di Mascio, M., Hu, Z., Srinivasula, S., Thaker, V., Adelsberger, J., Rupert, A. et al., HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 19851-19856.
26. Sieg, S. F., Rodriguez, B., Asaad, R., Jiang, W., Bazdar, D. A. and Lederman, M. M., Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T-cell receptor engagement. J. Infect. Dis. 2005. 192: 62-70.
27. Akbar, A. N., Borthwick, N., Salmon, M., Gombert, W., Bofill, M., Shamsadeen, N., Pilling, D. et al., The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T-cell memory. J. Exp. Med. 1993. 178: 427-438.
28. Blow, J. J. and Dutta, A., Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 2005. 6: 476-486.
29. Sherr, C. J. and Roberts, J. M., CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999. 13: 1501-1512.
30. Piedimonte, G., Corsi, D., Paiardini, M., Cannavo, G., Ientile, R., Picerno, I., Montroni, M. et al., Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients. AIDS 1999. 13: 1159-1164.
31. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C. and Altieri, D. C., Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998. 396: 580-584.
32. Konno, R., Yamakawa, H., Utsunomiya, H., Ito, K., Sato, S. and Yajima, A., Expression of survivin and Bcl-2 in the normal human endometrium. Mol. Hum. Reprod. 2000. 6: 529-534.
33. Toba, K., Winton, E. F., Koike, T. and Shibata, A., Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. J. Immunol. Methods 1995. 182: 193-207.
34. Darzynkiewicz, Z., Traganos, F. and Melamed, M. R., New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1980. 1: 98-108.
35. McFarland, R. D., Douek, D. C., Koup, R. A. and Picker, L. J., Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. USA 2000. 97: 4215-4220.
36. Connors, M., Kovacs, J. A., Krevat, S., Gea-Banacloche, J. C., Sneller, M. C., Flanigan, M., Metcalf, J. A. et al., HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 1997. 3: 533-540.
37. Lempicki, R. A., Kovacs, J. A., Baseler, M. W., Adelsberger, J. W., Dewar, R. L., Natarajan, V., Bosche, M. C. et al., Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T-cell turnover in HIV-infected patients. Proc. Natl. Acad. Sci. USA 2000. 97: 13778-13783.